Advertisement

Topics

Celgene pursues neuro breakthrough with $150m Prosena deal

19:55 EDT 20 Mar 2018 | pharmaphorum

Celgene is pushing further into the field of neuroscience and dementia research with an alliance with Dublin-based biotech Prosena. Celgene has become a ‘big biotech’ thanks to its stellar growth of its multiple myeloma blockbuster Revlimid, but i...

Original Article: Celgene pursues neuro breakthrough with $150m Prosena deal

NEXT ARTICLE

More From BioPortfolio on "Celgene pursues neuro breakthrough with $150m Prosena deal"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...